Brief: AC Immune Q3 Operating Income CHF -9.801 Million
04/11/2026 12:01
BRIEF-AC Immune Q3 Operating Income CHF -9.801 Million Nov 04 (Reuters) - AC Immune Q3 net income CHF -8.75 million.
- Q3 pretax profit CHF -8.75 million
- Q3 operating expenses CHF -13.045 million
- Q3 EPS CHF -0.13
Recent news on AC Immune AG
See all newsAC Immune AG reports results for the quarter ended September 30 - Earnings Summary
AC Immune Q3 net loss narrows as revenue rises
Brief: AC Immune Q3 Operating Income CHF -9.801 Million
AC Immune rises after Parkinson's drug shows promise in mid-stage trial
Brief: Ac Immune Reports Positive Safety & Immunogenicity At Week-100 In Part 1 Of Vacsyn Phase 2 Trial Of Aci-7104